GlassScriptPhysician profile
Nitesh Gadeela
NPI 1962525790
$48,331.42
in general payments reported to CMS, 2019-2025
46 companies · $5,230 in 2025
The $5,230 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,237 · 2021: $1,856 · 2022: $8,597 · 2023: $8,661 · 2024: $9,333 · 2025: $5,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $8,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,998.16 |
| Travel and Lodging | $8,225.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,522.58 | 2019-2025 | Ekosonic, Avvigo Guidance System, Eluvia |
| Janssen Pharmaceuticals, INC | $7,873.87 | 2019-2023 | Xarelto |
| Penumbra, INC. | $6,463.12 | 2020-2024 | Indigo System |
| Heartflow, INC. | $3,047.08 | 2022-2025 | Ffrct |
| Cardiovascular Systems INC. | $2,730.94 | 2019-2022 | |
| Abiomed | $660.67 | 2019-2025 | Impella |
| Pfizer INC. | $641.86 | 2019-2025 | |
| Abbott Laboratories | $589.08 | 2019-2025 | Pressurewire, Perclose Prostyle, Esprit |
| Astrazeneca Pharmaceuticals LP | $536.54 | 2019-2023 | Farxiga, Brilinta |
| Philips North America LLC | $525.67 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $518.00 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $434.56 | 2019-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Shockwave Medical, INC | $350.26 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $345.73 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Reflow Medical INC | $293.51 | 2024 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $278.17 | 2022-2023 | Verquvo |
| Amgen INC. | $273.66 | 2019-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $261.67 | 2022-2025 | Tr Band, Glidewire |
| Thrombolex, INC. | $212.14 | 2025 | Bashir Endovascular Catheter |
| Medtronic, INC. | $175.00 | 2022 | |
| Teleflex LLC | $169.34 | 2025 | Guideliner, Trapliner |
| Sanofi-Aventis U.S. LLC | $152.66 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.62 | 2019-2024 | Jardiance |
| Edwards Lifesciences Corporation | $135.12 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $133.17 | 2019-2023 | Camzyos |
| Biosense Webster, INC. | $127.89 | 2024 | Nuvision Ice Catheter |
| Chiesi USA, INC. | $91.95 | 2023-2025 | Kengreal |
| Regeneron Healthcare Solutions, INC. | $66.76 | 2019-2023 | Evkeeza |
| Gilead Sciences, INC. | $60.04 | 2019 | |
| Astellas Pharma US INC | $59.49 | 2019 | |
| Ekos Corporation | $53.42 | 2019 | |
| Cvrx, INC. | $50.81 | 2023 | Barostim Neo System |
| Angiodynamics, INC. | $46.62 | 2022-2024 | Alphavac |
| Novo Nordisk INC | $42.70 | 2019-2023 | Ozempic |
| Stryker Corporation | $38.00 | 2025 | Intri24 Introducer Sheath, Flowtriever |
| Actelion Pharmaceuticals US, INC. | $36.33 | 2023-2025 | Uptravi, Opsumit |
| Otsuka America Pharmaceutical, INC. | $34.25 | 2019 | |
| Amarin Pharma, INC. | $28.46 | 2019 | |
| Kestra Medical Technology Services, INC. | $24.31 | 2025 | Assure Wcd |
| Cordis US Corp. | $21.00 | 2022 | |
| Recor Medical INC | $17.90 | 2024 | Paradise Renal Denervation System |
| Portola Pharmaceuticals, LLC | $17.07 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.64 | 2023 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $16.43 | 2023 | Arcalyst |
| Daiichi Sankyo INC. | $12.47 | 2019 | |
| Acist Medical Systems, INC. | $5.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitesh Gadeela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.